Dominique Monnet
2019
In 2019, Dominique Monnet earned a total compensation of $6.7M as President and Chief Executive Officer at PDL BioPharma, a 168% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $508,000 |
|---|---|
| Option Awards | $3,822,000 |
| Salary | $635,000 |
| Stock Awards | $1,678,000 |
| Other | $58,000 |
| Total | $6,701,000 |
Monnet received $3.8M in option awards, accounting for 57% of the total pay in 2019.
Monnet also received $508K in non-equity incentive plan, $635K in salary, $1.7M in stock awards and $58K in other compensation.
Rankings
In 2019, Dominique Monnet's compensation ranked 1,455th out of 13,971 executives tracked by ExecPay. In other words, Monnet earned more than 89.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,455 out of 13,971 | 90th |
Division Manufacturing | 517 out of 5,701 | 91st |
Major group Chemicals And Allied Products | 158 out of 2,200 | 93rd |
Industry group Drugs | 126 out of 1,886 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 28 out of 389 | 93rd |
Source: SEC filing on July 7, 2020.
Monnet's colleagues
We found four more compensation records of executives who worked with Dominique Monnet at PDL BioPharma in 2019.